5 common questions about cervical cancer vaccination

It is currently believed that "high-risk" human papillomavirus (HPV) infection is a necessary factor for the occurrence of cervical cancer. With the continuous deepening of cervical cancer research, cervical cancer preventive vaccines have also begun to come into people's sight.

Here are 5 common questions about the cervical cancer vaccine:

1. What is the cervical cancer vaccine?

The main ingredient of the cervical cancer vaccine is inactive protein derived from human papillomavirus types 6, 11, 16, and 18, and the vaccine is made from the virus's coat.

2. Can the cervical cancer vaccine protect against all HPV infections?

There is currently no vaccine that can resist all HPV infections. Current cervical cancer vaccines mainly target HPV types 16, 18, 6, and 11.

3. When is the best time to get the cervical cancer vaccine?

The earlier the cervical cancer vaccine is administered, the better. It is most effective when administered before sexual intercourse. The injection age varies from place to place according to different national standards.

4. Is the cervical cancer vaccine safe?

The cervical cancer vaccine is not absolutely safe. Depending on your individual constitution, you may experience side effects such as fever, dizziness, swelling, and pain.

5. Is the cervical cancer vaccine effective for life?

Currently, the cervical cancer vaccine is generally effective for 5-7 years. For women who have already developed cervical tumors, there is no evidence that the vaccine can reverse the formation of cervical cancer, nor is there any evidence to determine whether the vaccine is effective for life.

Warm reminder: HPV infection is very common and is affected by many factors, so you should not rely too much on vaccines.